1-9 of 9
| Supplier | Product name | Cat.no. | Pack size | Price | ||
|---|---|---|---|---|---|---|
 |
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022) | 10-2004-100 | 283,20 |
|
||
|
|
Recombinant Anti-SARS-CoV-2 Nucleocapsid antibody (ABMX-004) | 10-2007-100 | 283,20 |
|
||
|
|
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (ABMX-002) | 10-2005-100 | 283,20 |
|
||
|
|
Recombinant Anti-SARS-CoV-2 Spike RBD antibody (ABMX-003) | 10-2006-100 | 283,20 |
|
||
|
|
Anti-BAFF Antibody (belimumab biosimilar) (LymphoStat-B) | 12-9104-50 | 319,20 |
|
||
|
|
Anti-BCMA Antibody (belantamab biosimilar) (J6M0) | 12-9088-50 | 319,20 |
|
||
|
|
Recombinant anti-human-Amyloid Beta Antibody (Lecanemab Biosimilar) | 12-9407-50 | 370,40 |
|
1-9 of 9
Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch
Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00
Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch
Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern
© Copyright 2021 Lucerna-Chem AG, Switzerland